Sinemet supply problems

MSD has warned that the availability of Sinemet (levodopa/carbidopa) will be reduced from late 2009 until 2011.

The global shortage of the Parkinson’s disease treatment, which is due to a change in supply source, will affect all presentations of Sinemet, Sinemet CR and Half Sinemet CR.

View Sinemet drug record

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the...

New MIMS table helps prescribers choose asthma inhalers

New MIMS table helps prescribers choose asthma inhalers

Prescribers can now turn to a handy MIMS comparison...

LABA/Corticosteroid Combination Inhalers for the Treatment of Asthma

LABA/Corticosteroid Combination Inhalers for the Treatment of Asthma

Key information on asthma combination inhalers.

MIMS Learning's top 25 learning modules in 2018: which topics were the hottest?

MIMS Learning's top 25 learning modules in 2018: which topics were the hottest?

Discover the hottest topics in primary care learning,...